Navigation Links
Preventice Expands Options for Wireless Patient Monitoring with Qualcomm Life
Date:5/24/2012

MINNEAPOLIS, May 24, 2012 /PRNewswire/ -- Preventice, Inc., a developer of mobile health applications and patient monitoring systems, announced today that it is the latest to join medical device manufacturers, application developers, health care services companies and payors that are integrating with Qualcomm Life Inc., a wholly owned subsidiary of Qualcomm Incorporated, and their 2net™ Ecosystem.

(Logo: http://photos.prnewswire.com/prnh/20120417/CG89172LOGO)

Preventice is a break-through developer of mobile health applications with an emphasis on remote patient monitoring systems that deliver continuous care. Preventice's cutting-edge solutions allow individuals to remain active and independent while their individual physiologic characteristics are being monitored with a simple and discreet body-worn sensor. Preventice will leverage Qualcomm Life's 2net Platform in order to provide chronic care patients with multiple remote connectivity options.

"Our work with Qualcomm Life supports the Preventice mobile health strategy that focuses on maintaining the critical physician-patient connection," said Jon Otterstatter, co-founder, president and CEO of Preventice. "The Preventice remote monitoring solutions together with the 2net Hub connectivity will not only allow providers to cost-effectively assess their patients' health and behaviors at any time, but it will further facilitate the secure data collection, transport and analysis essential to driving better health care outcomes and lowering costs."

Qualcomm Life's 2net Platform and Hub connects wireless medical devices via cloud-based solutions so that biometric information is easily accessible by device users, their health care providers and caregivers. The 2net Platform and Hub are intended to transfer, store, convert and display medical device data.

"The ability to store comprehensive patient data is an integral part of building mobile health applications and remote patient monitoring systems," said Rick Valencia, vice president and general manager of Qualcomm Life. "We are looking forward to working with Preventice to enhance connectivity and responsiveness of their offerings."

About Preventice

Preventice is a privately owned company and leading developer of mobile health applications and remote monitoring systems that connect mobile, home-based, and on-premise technologies to deliver continuous patient care across the health continuum—wherever an individual patient might be. Applications from Preventice create a constant connection and exchange of data between health care providers, life science companies and their patients. Current applications from Preventice address high-cost conditions and health management opportunities, including prescription medication management, cardiac care, sleep apnea, diabetes management, and migraine headaches. Preventice is headquartered in Minneapolis, with offices in Rochester, Minn., and Fargo, N.D. For more information, visit www.preventice.com.

Qualcomm is a registered trademark of Qualcomm Incorporated. 2net is a trademark of Qualcomm Incorporated. All other trademarks are the property of their respective owners.

For more information:

Colleen Kulhanek
+1-651-307-9486
Preventice

Barbara Tabor, APR
+1-651-230-9192
Tabor Communications Consulting for Preventice


'/>"/>
SOURCE Preventice
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. National Science Foundation grant expands UMCES oyster research
2. Research-based undergraduate course expands beyond Washington University
3. UNC expands brain imaging study of infants at risk for autism
4. Stowers Institutes Linheng Li Lab expands understanding of bone marrow stem cell niche
5. Springer expands its portfolio in plant sciences with Phytoparasitica
6. SVOX Acquires Speech Processing Unit of Siemens AG, Expands Into Speech Recognition and Speech Dialog
7. New book expands field data available on orangutans
8. Fetal alcohol syndrome testing expands
9. NIH expands Human Microbiome Project; funds sequencing centers and disease projects
10. Fujitsu Expands Support for Ethernet Networks With New Additions to XG Switch Product Line
11. ID Analytics Expands Availability of On-Demand Identity Intelligence Solutions for the Government Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2017)... The biometrics market has reached a ... organizations, desires to better authenticate or identify users ... challenge questions), biometrics is quickly working its way ... is driven by use cases, though there traditionally ... uses cases, with consumer-facing use cases encompassing authentication, ...
(Date:2/7/2017)... , Feb. 7, 2017 Zimmer Biomet Holdings, ... musculoskeletal healthcare, will present at the LEERINK Partners 6th ... Palace Hotel on Wednesday, February 15, 2017 at 10 ... of the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh ... the conference via Zimmer Biomet,s Investor Relations website at ...
(Date:2/3/2017)... Feb. 3, 2017  Texas Biomedical Research Institute announced that ... Larry Schlesinger as the Institute,s new President and CEO. ... May 31, 2017. He is currently the Chair of the ... Center for Microbial Interface Biology at Ohio State University. ... new President and CEO of Texas Biomed," said Dr. ...
Breaking Biology News(10 mins):
(Date:2/20/2017)... ... February 20, 2017 , ... ... teleradiology and telemedicine company announces at HIMSS 2017 Annual Conference (Orlando, FL) ... be offered via a global cloud-based sharing and collaboration platform as part ...
(Date:2/20/2017)... , Feb. 20, 2017  Atrius Health and ... entered into an agreement to develop a cloud ... By providing a holistic view of the multiple ... Watson Cognitive Insights could be designed to support ... Health is an innovative nonprofit healthcare organization with ...
(Date:2/18/2017)... 17, 2017 Research and Markets has announced ... report to their offering. ... The report provides separate comprehensive analytics for the ... and Rest of World. Annual estimates and forecasts are provided for ... provided for these markets. Market data and analytics are derived from ...
(Date:2/17/2017)... 2017  Protagonist Therapeutics, Inc. (NASDAQ: PTGX) today ... peptide drug candidates, PTG-100 and PTG-200, at the ... and Colitis Organization (ECCO).  The ECCO congress is ... from February 15 – 18, 2017. ... Protagonist drug candidates PTG-100 and PTG-200. PTG-100, a ...
Breaking Biology Technology: